BlackRock's position in DaVita is currently worth $532M. That's 0.01% of their equity portfolio (1099th largest holding). The investor owns 4.26% of the outstanding DaVita stock. The first DaVita trade was made in Q4 2020. Since then BlackRock bought shares three more times and sold shares on fourteen occasions. The stake costed the investor $282M, netting the investor a gain of 88% so far.
The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter res...
DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.